Literature DB >> 6737492

Acute cervical lymphadenitis in hospitalized pediatric patients: predominance of Staphylococcus aureus in infancy.

V I Ahonkhai, B Omokoku, M Rao.   

Abstract

Sixty-one cases of acute cervical lymphadenitis in Kings County Hospital Center were reviewed. Staphylococcus aureus accounted for 50 percent of the cases and Group A β-hemolytic streptococcus accounted for 15 percent; 35 percent had no growth on culture. Of the variables considered (age, sex, temperature, leukocytosis, previous antibiotic treatment, duration of symptoms, lymph node consistency) only age appeared to be a predictor of the causative organisms. Children under 1 year of age had a higher incidence of S aureus (65 percent) than children above 3 years of age (25 percent); the difference was statistically significant (P <.01). Therapeutic antimicrobial regimens should include coverage for S aureus in this age group.

Entities:  

Mesh:

Year:  1984        PMID: 6737492      PMCID: PMC2561676     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  5 in total

1.  Etiology of cervical lymphadenitis in children.

Authors:  A S DAJANI; R E GARCIA; E WOLINSKY
Journal:  N Engl J Med       Date:  1963-06-13       Impact factor: 91.245

2.  Staphylococcal cervical adenitis in young infants.

Authors:  J P Hieber; A T Davis
Journal:  Pediatrics       Date:  1976-03       Impact factor: 7.124

3.  Childhood cervical lymphadenitis: a reappraisal.

Authors:  L L Barton; R D Feigin
Journal:  J Pediatr       Date:  1974-06       Impact factor: 4.406

4.  Acute suppurative adenitis in children: a review of 964 cases.

Authors:  W G Scobie
Journal:  Scott Med J       Date:  1969-10       Impact factor: 0.729

5.  Pediatrics: cervical adenopathy in children.

Authors:  B D Schmitt
Journal:  Postgrad Med       Date:  1976-09       Impact factor: 3.840

  5 in total
  1 in total

1.  Suppurative lymphadenitis.

Authors:  Iain P Fraser
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.